10-Q Filing

PFIZER INC CIK: 78003 Q1 2023

Filing Information

Form Type	10-Q
Accession Number	`0001628280-23-017196`
Period End Date	20230331
Filing Date	20230510
Fiscal Year	2023
Fiscal Period	Q1
XBRL Instance	pfe-20230402_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 86 Income Statement 46 Cash Flow Statement 72 Stockholders Equity 21 Comprehensive Income 34

Balance Sheet 86 line items

Line Item	Tag	Value	Unit	Period
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$465.00M	USD	Point-in-time
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$449.00M	USD	Point-in-time
Property, plant and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$15.17B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.17B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$416.00M	USD	Point-in-time
Property, plant and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$15.51B	USD	Point-in-time
Short-term investments	`OtherShortTermInvestments`	$22.32B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$3.57B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$2.56B	USD	Point-in-time
Short-term investments	`OtherShortTermInvestments`	$17.81B	USD	Point-in-time
Trade accounts receivable, less allowance for doubtful accounts: 2023$465; 2022$449	`AccountsReceivableNetCurrent`	$12.30B	USD	Point-in-time
Trade accounts receivable, less allowance for doubtful accounts: 2023$465; 2022$449	`AccountsReceivableNetCurrent`	$10.95B	USD	Point-in-time
Inventories	`InventoryNet`	$9.54B	USD	Point-in-time
Inventories	`InventoryNet`	$8.98B	USD	Point-in-time
Current tax assets	`OtherTaxAssetsCurrent`	$3.58B	USD	Point-in-time
Current tax assets	`OtherTaxAssetsCurrent`	$3.14B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$5.02B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$5.12B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$50.08B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$51.26B	USD	Point-in-time
Equity-method investments	`EquityMethodInvestments`	$11.03B	USD	Point-in-time
Equity-method investments	`EquityMethodInvestments`	$11.18B	USD	Point-in-time
Long-term investments	`OtherLongTermInvestments`	$4.04B	USD	Point-in-time
Long-term investments	`OtherLongTermInvestments`	$3.57B	USD	Point-in-time
Property, plant and equipment, less accumulated depreciation: 2023$15,514; 2022$15,174	`PropertyPlantAndEquipmentNet`	$17.05B	USD	Point-in-time
Property, plant and equipment, less accumulated depreciation: 2023$15,514; 2022$15,174	`PropertyPlantAndEquipmentNet`	$16.27B	USD	Point-in-time
Identifiable intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$43.37B	USD	Point-in-time
Identifiable intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$42.00B	USD	Point-in-time
Goodwill	`Goodwill`	$51.48B	USD	Point-in-time
Goodwill	`Goodwill`	$51.38B	USD	Point-in-time
Noncurrent deferred tax assets and other noncurrent tax assets	`DeferredTaxAssetsNetAndOtherTaxAssetsNoncurrent`	$7.30B	USD	Point-in-time
Noncurrent deferred tax assets and other noncurrent tax assets	`DeferredTaxAssetsNetAndOtherTaxAssetsNoncurrent`	$6.69B	USD	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$12.96B	USD	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$13.16B	USD	Point-in-time
Total assets	`Assets`	$197.21B	USD	Point-in-time
Total assets	`Assets`	$195.62B	USD	Point-in-time
Short-term borrowings, including current portion of long-term debt: 2023$3,567; 2022$2,560	`DebtCurrent`	$4.19B	USD	Point-in-time
Short-term borrowings, including current portion of long-term debt: 2023$3,567; 2022$2,560	`DebtCurrent`	$2.94B	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$6.12B	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$6.81B	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$2.30B	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	-	USD	Point-in-time
Income taxes payable	`TaxesPayableCurrent`	$1.97B	USD	Point-in-time
Income taxes payable	`TaxesPayableCurrent`	$1.59B	USD	Point-in-time
Accrued compensation and related items	`EmployeeRelatedLiabilitiesCurrent`	$3.41B	USD	Point-in-time
Accrued compensation and related items	`EmployeeRelatedLiabilitiesCurrent`	$2.28B	USD	Point-in-time
Deferred revenues	`ContractWithCustomerLiabilityCurrent`	$1.75B	USD	Point-in-time
Deferred revenues	`ContractWithCustomerLiabilityCurrent`	$2.52B	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$20.25B	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$22.57B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$42.14B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$36.56B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$32.88B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$31.70B	USD	Point-in-time
Pension and postretirement benefit obligations	`PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent`	$2.18B	USD	Point-in-time
Pension and postretirement benefit obligations	`PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent`	$2.25B	USD	Point-in-time
Noncurrent deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$1.07B	USD	Point-in-time
Noncurrent deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$1.02B	USD	Point-in-time
Other taxes payable	`LiabilityForUncertainTaxPositionsNoncurrent`	$9.86B	USD	Point-in-time
Other taxes payable	`LiabilityForUncertainTaxPositionsNoncurrent`	$9.81B	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$13.18B	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$13.01B	USD	Point-in-time
Total liabilities	`Liabilities`	$94.38B	USD	Point-in-time
Total liabilities	`Liabilities`	$101.29B	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock	`CommonStockValue`	$476.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$478.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$92.15B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$91.80B	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$114.47B	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$113.97B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$131.10B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$125.66B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-8.29B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-8.30B	USD	Point-in-time
Total Pfizer Inc. shareholders equity	`StockholdersEquity`	$95.66B	USD	Point-in-time
Total Pfizer Inc. shareholders equity	`StockholdersEquity`	$100.97B	USD	Point-in-time
Equity attributable to noncontrolling interests	`MinorityInterest`	$256.00M	USD	Point-in-time
Equity attributable to noncontrolling interests	`MinorityInterest`	$266.00M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$101.24B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$82.69B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$77.46B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$95.92B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$197.21B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$195.62B	USD	Point-in-time

Income Statement 46 line items

Line Item	Tag	Value	Unit	Period
Revenues	`Revenues`	$25.66B	USD	1 Quarter
Revenues	`Revenues`	$18.28B	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$9.98B	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$4.89B	USD	1 Quarter
Selling, informational and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$3.42B	USD	1 Quarter
Selling, informational and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$2.59B	USD	1 Quarter
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$2.30B	USD	1 Quarter
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$2.50B	USD	1 Quarter
Acquired in-process research and development expenses	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$21.00M	USD	1 Quarter
Acquired in-process research and development expenses	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$355.00M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssetsNotAssociatedWithSingleFunction`	$835.00M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssetsNotAssociatedWithSingleFunction`	$1.10B	USD	1 Quarter
Restructuring charges and certain acquisition-related costs	`RestructuringChargesAndAcquisitionRelatedCosts`	$192.00M	USD	1 Quarter
Restructuring charges and certain acquisition-related costs	`RestructuringChargesAndAcquisitionRelatedCosts`	$9.00M	USD	1 Quarter
Other (income)/deductionsnet	`OtherNonoperatingIncomeExpense`	$-70.00M	USD	1 Quarter
Other (income)/deductionsnet	`OtherNonoperatingIncomeExpense`	$-350.00M	USD	1 Quarter
Income from continuing operations before provision/(benefit) for taxes on income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$9.05B	USD	1 Quarter
Income from continuing operations before provision/(benefit) for taxes on income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$6.27B	USD	1 Quarter
Provision/(benefit) for taxes on income	`IncomeTaxExpenseBenefit`	$715.00M	USD	1 Quarter
Provision/(benefit) for taxes on income	`IncomeTaxExpenseBenefit`	$1.17B	USD	1 Quarter
Income from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$5.55B	USD	1 Quarter
Income from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$7.88B	USD	1 Quarter
Discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$1.00M	USD	1 Quarter
Discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-9.00M	USD	1 Quarter
Net income before allocation to noncontrolling interests	`ProfitLoss`	$5.56B	USD	1 Quarter
Net income before allocation to noncontrolling interests	`ProfitLoss`	$7.87B	USD	1 Quarter
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$13.00M	USD	1 Quarter
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$6.00M	USD	1 Quarter
Net income attributable to Pfizer Inc. common shareholders	`NetIncomeLoss`	$7.86B	USD	1 Quarter
Net income attributable to Pfizer Inc. common shareholders	`NetIncomeLoss`	$5.54B	USD	1 Quarter
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$0.98	USD	1 Quarter
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$1.40	USD	1 Quarter
Discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	-	USD	1 Quarter
Discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	-	USD	1 Quarter
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareBasic`	$1.40	USD	1 Quarter
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareBasic`	$0.98	USD	1 Quarter
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$1.37	USD	1 Quarter
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$0.97	USD	1 Quarter
Discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	-	USD	1 Quarter
Discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	-	USD	1 Quarter
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareDiluted`	$1.37	USD	1 Quarter
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareDiluted`	$0.97	USD	1 Quarter
Weighted-average sharesbasic	`WeightedAverageNumberOfSharesOutstandingBasic`	5.63B	shares	1 Quarter
Weighted-average sharesbasic	`WeightedAverageNumberOfSharesOutstandingBasic`	5.62B	shares	1 Quarter
Weighted-average sharesdiluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	5.73B	shares	1 Quarter
Weighted-average sharesdiluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	5.76B	shares	1 Quarter

Cash Flow Statement 72 line items

Line Item	Tag	Value	Unit	Period
Net income before allocation to noncontrolling interests	`ProfitLoss`	$5.56B	USD	1 Quarter
Net income before allocation to noncontrolling interests	`ProfitLoss`	$7.87B	USD	1 Quarter
Discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-9.00M	USD	1 Quarter
Discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$1.00M	USD	1 Quarter
Net income from continuing operations before allocation to noncontrolling interests	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$7.88B	USD	1 Quarter
Net income from continuing operations before allocation to noncontrolling interests	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$5.55B	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortizationIncludingDiscontinuedOperationDepreciationandAmortization`	$1.49B	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortizationIncludingDiscontinuedOperationDepreciationandAmortization`	$1.19B	USD	1 Quarter
Asset write-offs and impairments	`AssetWriteOffsAndAssetImpairmentCharges`	$31.00M	USD	1 Quarter
Asset write-offs and impairments	`AssetWriteOffsAndAssetImpairmentCharges`	$270.00M	USD	1 Quarter
Deferred taxes	`DeferredIncomeTaxExpenseBenefit`	$-598.00M	USD	1 Quarter
Deferred taxes	`DeferredIncomeTaxExpenseBenefit`	$-2.32B	USD	1 Quarter
Share-based compensation expense	`ShareBasedCompensation`	$105.00M	USD	1 Quarter
Share-based compensation expense	`ShareBasedCompensation`	$86.00M	USD	1 Quarter
Benefit plan contributions in excess of expense/income	`PensionAndOtherPostretirementBenefitContributionsNetOfPensionAndOtherPostretirementBenefitExpense`	$404.00M	USD	1 Quarter
Benefit plan contributions in excess of expense/income	`PensionAndOtherPostretirementBenefitContributionsNetOfPensionAndOtherPostretirementBenefitExpense`	$200.00M	USD	1 Quarter
Other adjustments, net	`OtherNoncashIncomeExpense`	$-99.00M	USD	1 Quarter
Other adjustments, net	`OtherNoncashIncomeExpense`	$-815.00M	USD	1 Quarter
Other changes in assets and liabilities, net of acquisitions and divestitures	`IncreaseDecreaseInOperatingCapital`	$730.00M	USD	1 Quarter
Other changes in assets and liabilities, net of acquisitions and divestitures	`IncreaseDecreaseInOperatingCapital`	$5.51B	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$6.54B	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.21B	USD	1 Quarter
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.14B	USD	1 Quarter
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$643.00M	USD	1 Quarter
Purchases of short-term investments	`PaymentsToAcquireShortTermInvestments`	$8.76B	USD	1 Quarter
Purchases of short-term investments	`PaymentsToAcquireShortTermInvestments`	$6.67B	USD	1 Quarter
Proceeds from redemptions/sales of short-term investments	`ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments`	$13.42B	USD	1 Quarter
Proceeds from redemptions/sales of short-term investments	`ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments`	$6.40B	USD	1 Quarter
Net (purchases of)/proceeds from redemptions/sales of short-term investments with original maturities of three months or less	`PaymentsForProceedsFromShortTermInvestmentsWithOriginalMaturitiesOfThreeMonthsOrLess`	$-4.67B	USD	1 Quarter
Net (purchases of)/proceeds from redemptions/sales of short-term investments with original maturities of three months or less	`PaymentsForProceedsFromShortTermInvestmentsWithOriginalMaturitiesOfThreeMonthsOrLess`	$-3.41B	USD	1 Quarter
Purchases of long-term investments	`PaymentsToAcquireMarketableSecurities`	$676.00M	USD	1 Quarter
Purchases of long-term investments	`PaymentsToAcquireMarketableSecurities`	$51.00M	USD	1 Quarter
Proceeds from redemptions/sales of long-term investments	`ProceedsFromSaleMaturityAndCollectionOfLongtermInvestments`	$124.00M	USD	1 Quarter
Proceeds from redemptions/sales of long-term investments	`ProceedsFromSaleMaturityAndCollectionOfLongtermInvestments`	$52.00M	USD	1 Quarter
Acquisition of business, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$6.22B	USD	1 Quarter
Acquisition of business, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	1 Quarter
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$18.00M	USD	1 Quarter
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$13.00M	USD	1 Quarter
Net cash provided by/(used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$3.31B	USD	1 Quarter
Net cash provided by/(used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$567.00M	USD	1 Quarter
Proceeds from short-term borrowings	`ProceedsFromShortTermDebt`	$11.00M	USD	1 Quarter
Proceeds from short-term borrowings	`ProceedsFromShortTermDebt`	-	USD	1 Quarter
Net (payments on)/proceeds from short-term borrowings with original maturities of three months or less	`ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess`	$226.00M	USD	1 Quarter
Net (payments on)/proceeds from short-term borrowings with original maturities of three months or less	`ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess`	$-220.00M	USD	1 Quarter
Payments on long-term debt	`RepaymentsOfLongTermDebt`	$1.61B	USD	1 Quarter
Payments on long-term debt	`RepaymentsOfLongTermDebt`	$269.00M	USD	1 Quarter
Purchases of common stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	1 Quarter
Purchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$2.00B	USD	1 Quarter
Cash dividends paid	`PaymentsOfOrdinaryDividends`	$2.30B	USD	1 Quarter
Cash dividends paid	`PaymentsOfOrdinaryDividends`	$2.25B	USD	1 Quarter
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-501.00M	USD	1 Quarter
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-436.00M	USD	1 Quarter
Net cash provided by/(used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-6.58B	USD	1 Quarter
Net cash provided by/(used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-2.77B	USD	1 Quarter
Effect of exchange-rate changes on cash and cash equivalents and restricted cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-2.00M	USD	1 Quarter
Effect of exchange-rate changes on cash and cash equivalents and restricted cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-1.00M	USD	1 Quarter
Net increase/(decrease) in cash and cash equivalents and restricted cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$529.00M	USD	1 Quarter
Net increase/(decrease) in cash and cash equivalents and restricted cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.75B	USD	1 Quarter
Cash and cash equivalents and restricted cash and cash equivalents, at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$468.00M	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.51B	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.98B	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.22B	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$468.00M	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.51B	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.98B	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.22B	USD	Point-in-time
Income taxes	`IncomeTaxesPaidNet`	$329.00M	USD	1 Quarter
Income taxes	`IncomeTaxesPaidNet`	$354.00M	USD	1 Quarter
Interest paid	`InterestPaidNet`	$419.00M	USD	1 Quarter
Interest paid	`InterestPaidNet`	$453.00M	USD	1 Quarter
Interest rate hedges	`InterestPaidReceivedInterestRateHedges`	$26.00M	USD	1 Quarter
Interest rate hedges	`InterestPaidReceivedInterestRateHedges`	$60.00M	USD	1 Quarter

Stockholders Equity 21 line items

Line Item	Tag	Value	Unit	Period
Cash dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	-	USD	1 Quarter
Cash dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	-	USD	1 Quarter
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$101.24B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$82.69B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$77.46B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$95.92B	USD	Point-in-time
Net income	`ProfitLoss`	$5.56B	USD	1 Quarter
Net income	`ProfitLoss`	$7.87B	USD	1 Quarter
Other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-260.00M	USD	1 Quarter
Other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$12.00M	USD	1 Quarter
Common stock	`DividendsCommonStockCash`	-	USD	1 Quarter
Common stock	`DividendsCommonStockCash`	-	USD	1 Quarter
Share-based payment transactions	`StockIssuedDuringPeriodValueShareBasedCompensation`	$-249.00M	USD	1 Quarter
Share-based payment transactions	`StockIssuedDuringPeriodValueShareBasedCompensation`	$-383.00M	USD	1 Quarter
Purchases of common stock	`TreasuryStockValueAcquiredCostMethod`	$2.00B	USD	1 Quarter
Other	`StockholdersEquityOther`	-	USD	1 Quarter
Other	`StockholdersEquityOther`	$4.00M	USD	1 Quarter
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$101.24B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$82.69B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$77.46B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$95.92B	USD	Point-in-time

Comprehensive Income 34 line items

Line Item	Tag	Value	Unit	Period
Net income before allocation to noncontrolling interests	`ProfitLoss`	$5.56B	USD	1 Quarter
Net income before allocation to noncontrolling interests	`ProfitLoss`	$7.87B	USD	1 Quarter
Foreign currency translation adjustments, net	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax`	$101.00M	USD	1 Quarter
Foreign currency translation adjustments, net	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax`	$-363.00M	USD	1 Quarter
Unrealized holding gains/(losses) on derivative financial instruments, net	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax`	$2.00M	USD	1 Quarter
Unrealized holding gains/(losses) on derivative financial instruments, net	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax`	$203.00M	USD	1 Quarter
Reclassification adjustments for (gains)/losses included in net income	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax`	$-303.00M	USD	1 Quarter
Reclassification adjustments for (gains)/losses included in net income	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax`	$213.00M	USD	1 Quarter
Other comprehensive income (loss), derivatives qualifying as hedges, before tax, total	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax`	$305.00M	USD	1 Quarter
Other comprehensive income (loss), derivatives qualifying as hedges, before tax, total	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax`	$-10.00M	USD	1 Quarter
Unrealized holding gains/(losses) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$87.00M	USD	1 Quarter
Unrealized holding gains/(losses) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-133.00M	USD	1 Quarter
Reclassification adjustments for (gains)/losses included in net income	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$509.00M	USD	1 Quarter
Reclassification adjustments for (gains)/losses included in net income	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$-233.00M	USD	1 Quarter
Other comprehensive income (loss), available-for-sale securities, before tax, total	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax`	$99.00M	USD	1 Quarter
Other comprehensive income (loss), available-for-sale securities, before tax, total	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax`	$-422.00M	USD	1 Quarter
Reclassification adjustments related to amortization of prior service costs and other, net	`OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax`	$-30.00M	USD	1 Quarter
Reclassification adjustments related to amortization of prior service costs and other, net	`OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax`	$-36.00M	USD	1 Quarter
Reclassification adjustments related to curtailments of prior service costs and other, net	`OtherComprehensiveIncomeLossCurtailmentAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetPriorServiceCostCreditbeforeTax`	$-11.00M	USD	1 Quarter
Reclassification adjustments related to curtailments of prior service costs and other, net	`OtherComprehensiveIncomeLossCurtailmentAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetPriorServiceCostCreditbeforeTax`	$-5.00M	USD	1 Quarter
Defined benefit plan, amounts recognized in other comprehensive income (loss), net prior service cost, before tax	`DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax`	$47.00M	USD	1 Quarter
Defined benefit plan, amounts recognized in other comprehensive income (loss), net prior service cost, before tax	`DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax`	$35.00M	USD	1 Quarter
Other comprehensive income/(loss), before tax	`OtherComprehensiveIncomeLossBeforeTax`	$-321.00M	USD	1 Quarter
Other comprehensive income/(loss), before tax	`OtherComprehensiveIncomeLossBeforeTax`	$-50.00M	USD	1 Quarter
Tax provision/(benefit) on other comprehensive income/(loss)	`OtherComprehensiveIncomeLossTax`	$-60.00M	USD	1 Quarter
Tax provision/(benefit) on other comprehensive income/(loss)	`OtherComprehensiveIncomeLossTax`	$-63.00M	USD	1 Quarter
Other comprehensive income/(loss) before allocation to noncontrolling interests	`OtherComprehensiveIncomeLossNetOfTax`	$-260.00M	USD	1 Quarter
Other comprehensive income/(loss) before allocation to noncontrolling interests	`OtherComprehensiveIncomeLossNetOfTax`	$12.00M	USD	1 Quarter
Comprehensive income/(loss) before allocation to noncontrolling interests	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$5.57B	USD	1 Quarter
Comprehensive income/(loss) before allocation to noncontrolling interests	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$7.61B	USD	1 Quarter
Less: Comprehensive income/(loss) attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$10.00M	USD	1 Quarter
Less: Comprehensive income/(loss) attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$6.00M	USD	1 Quarter
Comprehensive income/(loss) attributable to Pfizer Inc.	`ComprehensiveIncomeNetOfTax`	$7.60B	USD	1 Quarter
Comprehensive income/(loss) attributable to Pfizer Inc.	`ComprehensiveIncomeNetOfTax`	$5.56B	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.